Main Menu

Cellular Biomedicine Group, Inc.

(NASDAQ GS: CBMG)

Rigrodsky Law, P.A. is investigating Cellular Biomedicine Group, Inc. (“CBMG”) regarding possible breaches of fiduciary duties and other violations of law related to CBMG’s agreement to be acquired by a consortium including CBMG CEO Bizuo (Tony) Liu and others.  Under the terms of the agreement, CBMG’s shareholders will receive $19.75 per share in cash.

Join This Action

Alternatively, you may upload your transactions using the upload button below or email them to info@rl-legal.com.

Draw your signature below using your mouse* [Clear]

Signed pursuant to California Civil Code Section 1633.1, et seq. - and the Uniform Electronic Transactions Act as adopted by the various states and territories of the United States.

Date of signing: 01/22/2021


* Indicates a required field.

Back to Page